Medical device instructions for use, drafted from your technical documentation and risk file
An IFU is regulated labelling. Its intended purpose has to match the technical documentation word for word, its warnings have to come from the risk management file, and its symbols have to match the label in the box. INKFLOW drafts medical device instructions for use from the documents your regulatory and design teams already control.
Name the device in the brief and the writer works from guidance for medical device IFUs. It asks for device identity and UDI-DI, classification and target markets, intended purpose and users, residual risks and warnings, clinical benefits and performance, materials and sterility, the validated use steps, reprocessing parameters, specifications, label symbols and the addresses of the economic operators.
In plain terms: the draft is written from your approved data, missing values are placeholders, and the IFU must go through your own regulatory affairs and clinical review before release. It does not certify compliance with the MDR, UK rules or FDA requirements. INKFLOW is independent; it is not a notified body, an approved body or a regulator, and responsibility for the content stays with you as manufacturer.
Medical device IFU drafting, in four hand-offs
- 1Identify the device and marketsDevice name, models, catalogue numbers and UDI-DI, the classification, and whether it is for Great Britain, Northern Ireland, the EU, the US or several, since each sets its own content.
- 2Release the controlled textIntended purpose, indications, contraindications, users and patient population exactly as in the technical documentation, and the residual risks the risk file says users must be told about.
- 3Supply the use and reprocessing dataThe validated use sequence, ideally from usability engineering, with figures; cleaning, disinfection and sterilisation parameters with cycle limits; or the reasons a single-use device must not be reused.
- 4Regulatory and clinical reviewPayment follows a quote you can read first. The draft carries a sign-off page; your regulatory affairs and clinical reviewers check it against the file and approve it under your document numbering.
What the instructions for use cover
IFU rules the draft follows, and the decisions it leaves to you
In the EU the Medical Device Regulation sets out the information that must accompany a device; Great Britain and Northern Ireland currently follow different routes; in the US, FDA labelling rules apply. The draft follows the markets you name. Whether a statement will satisfy a notified body or a regulator is decided in your review, not by the writer.
Clinical performance claims appear only as your clinical evaluation states them. INKFLOW will not round an accuracy figure, widen an indication or soften a contraindication.